How the Brain Removes Its Own Connections: Part Four: Human Cells, and What a Dish Cannot Show

Abstract

Three parts of this series have described a mechanism established in mice and in cultured rodent cells. This part covers the only study of the four that used human material, and it is the reason the topic reaches beyond neuroscience.

Carl Sellgren and colleagues built a system in which microglia-like cells and neurons, both derived from living people, prune synapses in a dish. Cells derived from patients with schizophrenia removed synapses faster than cells from controls.

It is the most human-relevant result in the field and it is still cells in a dish, which the authors say more clearly than most.

1.The Trick

You cannot take microglia from a living person's brain. The obstacle is absolute, and it is why almost everything in Parts One to Three is rodent.

The workaround has two halves. Microglia-like cells were induced from blood monocytes, cultured under conditions resembling the central nervous system environment — the authors' position being that monocytes cultured this way recapitulate important traits of primary human microglia. Neurons were derived separately, from skin fibroblasts, via induced pluripotent stem cells.

Both cell types therefore come from a living, diagnosable person, carrying that person's genome. Put them together and you have human pruning, running in front of a microscope.

The live imaging experiments used cells from 13 patients with schizophrenia and 9 healthy controls.

2.What Happened

Patient-derived microglia-like cells took up more synaptic material than control-derived cells. The difference reached statistical significance at three to five hours in live imaging, and confocal microscopy confirmed increased phagocytic inclusions in the patient-derived models at a p-value below 0.0001.

This is the in-vitro counterpart of a long-standing observation about schizophrenia: reduced synaptic density in cortex, with onset in adolescence — the developmental window when pruning peaks.

The correspondence between an epidemiological pattern and a cellular measurement in a dish is what made this paper influential.

3.Complement C4, and the Careful Sentence

Schizophrenia's strongest common genetic association lies in a region containing the complement component 4 gene, with risk tracking increased C4A expression. That was the prior hypothesis this study could test.

It found support: C4AL copy number correlated strongly with neuronal C3 complement deposition, with a rank correlation of 0.75 at a p-value of 0.002, and with synapse engulfment.

Then the sentence that distinguishes this paper from its coverage. The authors state that the observed effects are not fully attributable to effects of human C4 risk variants, and that additional unidentified mechanisms contribute to excessive pruning.

The genetics explains part of it. Something else, not yet identified, explains the rest — in a paper whose finding is routinely summarised as showing that a schizophrenia risk gene causes excessive synaptic pruning.

4.What a Dish Cannot Show

The authors' stated limitations are unusually specific and worth reproducing rather than paraphrasing away.

Induced microglia-like cells do not fully recapitulate the molecular signature of human microglia taken directly from tissue. Spine composition in stem-cell-derived neural cultures may not fully recapitulate conditions in a living brain.

And on the intervention they tested: there is no direct evidence that the effects of minocycline observed in vitro are themselves the cause of the lower incidence of schizophrenia associated with that drug in epidemiological data.

That third limitation is the one to hold onto. A drug reduced pruning in the dish, and a separate body of population data associates the same drug with lower schizophrenia incidence. The two facts sit next to each other and the authors decline to join them. Most reporting joins them.

5.Where Four Papers Leave It

Microglia remove synapses as a normal part of circuit development and continue doing so through life. Exposed phosphatidylserine marks which synapses go, and complement proteins with the receptor TREM2 form the recognition machinery. Astrocytes do a substantial share of the removing, preferentially of excitatory connections, through the same complement tag. And in human-derived cells, material from patients with schizophrenia prunes faster, partly but not wholly explained by a known risk gene.

That is a coherent mechanism with one human-derived study attached, no human tissue measurement, and no intervention tested in a person.

It is a great deal more than most of what this library covers, and it is not yet a basis for doing anything.

Editorial Comment

MindHeaven® makes no claim relating to synaptic pruning, microglia, complement or neuroinflammation. No ingredient in our formulations is proposed to influence any of them, and we would treat a supplement sold on this mechanism as making a promise the science has not made.

That warning is not hypothetical. "Reduces neuroinflammation" appears on products across this category, borrowing the credibility of the literature described in these four parts without touching any measurement in it.

Schizophrenia is a serious psychiatric illness, and nothing in this series is guidance about it. If the material here is of personal rather than scientific interest — because of a diagnosis in a family — the people worth talking to are clinicians, and the treatments that work are not on any supplement shelf.